VX1.DE

Vertex Pharmaceuticals Incorporated VX1.DE

VX1.DE
Vertex Pharmaceuticals Incorporated TN8.DE
Thermo Fisher Scientific Inc. GIS.DE
Gilead Sciences, Inc. INL.DE
Intel Corporation ILU.DE
Illumina, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VX1.DE TN8.DE GIS.DE INL.DE ILU.DE
6M -19.84 % 14.38 % 9.48 % 70.85 % 17.09 %
YTD -11.13 % -11.90 % 13.27 % 53.92 % -39.86 %
1Y -20.57 % -19.09 % 28.95 % 45.05 % -42.56 %
3Y 16.66 % -14.44 % 50.71 % 13.47 % -65.02 %
5Y 90.22 % 1 016.53 % 89.68 % -33.84 % -72.05 %
10Y 828.06 % 1 016.53 % 16.25 % 5.57 % 42.69 %
From the beginning 1 180.76 % 1 343.21 % 7 121.28 % -14.82 % 606.82 %

Dividend

Thermo Fisher Scientific Inc.

Gilead Sciences, Inc.

Intel Corporation